首页> 外国专利> COMPOUNDS AND METHODS OF STRENGTHENING THE DEGRADATION OF TARGET TARGETS AND OTHER POLYPEPTIDES USING E3 UBQUITIN LIGASES

COMPOUNDS AND METHODS OF STRENGTHENING THE DEGRADATION OF TARGET TARGETS AND OTHER POLYPEPTIDES USING E3 UBQUITIN LIGASES

机译:使用E3卵磷脂连接酶加强降解目标靶标和其他多肽的化合物和方法

摘要

1. The compound represented by the chemical structure: L-ULM, where L is a linker group, and ULM is a small molecule of the binding fragment of the ubiquitin ligase, which has a -OH substituent or a group that can be metabolized in the patient or subject to -OH where the ULM optionally contains a prolyl group, and where the linker group, in addition, is optionally associated with a fragment of the target protein (PTM). 2. A compound represented by the chemical structure: ULM-L-PTM, containing a small molecule of a binding fragment of a ubiquitin ligase (ULM), a fragment of a target protein (PTM) and a linker (L), where: ULM contains a group substituted by hydroxyl or a functional group which may be metabolized in the patient's body or converted to hydroxyl; L is a bond or chemical linker; PTM is attached to a target protein or polypeptide that must be ubiquitinylated with a ubiquitin ligase; ULM is chemically bound to L; and L is chemically bound to PTM; or a pharmaceutically acceptable salt, enantiomer, stereoisomer, solvate, polymorph or prodrug thereof. 3. A compound according to claim 2, wherein the compound comprises a plurality of ULMs, a plurality of PTMs, a plurality of linkers, or any combination thereof. The compound of claim 1, wherein the ULM contains a group having a chemical structure: http: //patentimages.storage.googleapis.com/WO2013106643A2/imgf000312_0001.png, where R is —OH or a group that can be metabolized in the patient or subject. to —OH; X and X ′ each independently represent C = O, C = S, S (O), S (O); R is selected from the group consisting of: optionally substituted - (CH) - (C = O) (NR) (SO) (CC) alkyl group, optionally substituted group RR- (CH) - (C = O) (NR) (SO) NRR, optionally substituted - (CH) - (C = O) (NR) ( SO) aryl optionally substituted with - (CH) - (C = O) (NR) (SO) heteroaryl optionally substituted with - (CH) - (C = O) NR (SO) -ge terocycle optionally substituted
机译:1.以下列化学结构表示的化合物:L-ULM,其中L为连接基,ULM为泛素连接酶结合片段的小分子,其具有-OH取代基或可在其中代谢的基团-OH的患者或受试者,其中ULM可选地包含一个脯氨酰基,并且该连接基团另外还与目标蛋白(PTM)的片段相关。 2.一种由以下化学结构代表的化合物:ULM-L-PTM,包含小分子的泛素连接酶(ULM)结合片段,目标蛋白的片段(PTM)和接头(L),其中: ULM包含被羟基取代的基团或可以在患者体内代谢或转化为羟基的官能团; L是键或化学接头; PTM附着在必须用泛素连接酶泛素化的靶蛋白或多肽上; ULM与L化学键合; L与PTM化学键合;或其药学上可接受的盐,对映异构体,立体异构体,溶剂化物,多晶型物或前药。 3.根据权利要求2所述的化合物,其中所述化合物包括多个ULM,多个PTM,多个接头或其任意组合。 3.根据权利要求1所述的化合物,其中,所述ULM包含具有化学结构的基团:http://patentimages.storage.googleapis.com/WO2013106643A2/imgf000312_0001.png其中R是-OH或可以在患者体内代谢的基团或主题。至-OH; X和X′分别独立地表示C = O,C = S,S(O),S(O); R选自以下基团:任选取代的-(CH)-(C = O)(NR)(SO)(CC)烷基,任选取代的基团RR-(CH)-(C = O)(NR) (SO)NRR,可选取代--(CH)-(C = O)(NR)(SO)芳基可选取代--(CH)-(C = O)(NR)(SO)杂芳基可选取代--(CH )-(C = O)NR(SO)-ge杂环可选取代

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号